Change in agitation in Alzheimer's disease in the placebo arm of a 9-week controlled trial

BACKGROUND: Placebo responses raise significant challenges for design of clinical trials. We report changes in agitation outcomes in the placebo arm of a recent trial of citalopram for agitation in Alzheimer's disease (AD). METHODS: In the Citalopram for Agitation in Alzheimer's Disease (C...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Int Psychogeriatr
Main Authors: Rosenberg, Paul B., Drye, Lea T., Porsteinsson, Anton P., Pollock, Bruce G., Devanand, D.P., Frangakis, Constantine, Ismail, Zahinoor, Marano, Christopher, Meinert, Curtis L., Mintzer, Jacobo E., Munro, Cynthia A., Pelton, Gregory, Rabins, Peter V., Schneider, Lon S., Shade, David M., Weintraub, Daniel, Newell, Jeffery, Yesavage, Jerome, Lyketsos, Constantine G.
Formato: Artigo
Idioma:Inglês
Publicado em: 2015
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4669064/
https://ncbi.nlm.nih.gov/pubmed/26305876
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1017/S1041610215001106
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados